JW Pharmaceutical Corp (001065) — Capital Reinvestment Ratio
JW Pharmaceutical Corp (001065) has a Capital Reinvestment Ratio of 0.11x as of June 2026, meaning it reinvests 0% of its operating cash flow (₩42.51 Billion) in capital expenditures (₩4.52 Billion). Check JW Pharmaceutical Corp (001065) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
JW Pharmaceutical Corp Capital Reinvestment Ratio (2014–2025)
This chart tracks JW Pharmaceutical Corp's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see JW Pharmaceutical Corp (001065) cash flow conversion.
Annual Capital Reinvestment Ratio for JW Pharmaceutical Corp (2014–2025)
Year-by-year Capital Reinvestment Ratio for JW Pharmaceutical Corp from 2014 to 2025. See JW Pharmaceutical Corp free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.37x | ₩96.40 Billion | ₩36.12 Billion | ▲ +5.7% |
| 2024 | 0.35x | ₩79.39 Billion | ₩28.14 Billion | ▼ -24.1% |
| 2023 | 0.47x | ₩87.16 Billion | ₩40.71 Billion | ▲ +167.3% |
| 2022 | 0.17x | ₩56.76 Billion | ₩9.92 Billion | ▼ -57.6% |
| 2021 | 0.41x | ₩18.12 Billion | ₩7.47 Billion | ▲ +109.7% |
| 2020 | 0.20x | ₩63.05 Billion | ₩12.39 Billion | ▲ +17.5% |
| 2019 | 0.17x | ₩55.53 Billion | ₩9.28 Billion | ▲ +0.9% |
| 2018 | 0.17x | ₩52.11 Billion | ₩8.64 Billion | ▼ -26.1% |
| 2017 | 0.22x | ₩33.45 Billion | ₩7.50 Billion | ▼ -84.9% |
| 2016 | 1.49x | ₩6.74 Billion | ₩10.02 Billion | ▲ +56.2% |
| 2014 | 0.95x | ₩7.28 Billion | ₩6.93 Billion | — |